Pasar al contenido principal

CARACTERIZACION FUNCIONAL E INTERVENCION DE UNA NUEVA RUTA DE SEÑALIZACION DE LA NEUROINFLAMACION MEDIADA POR MICROGLIA EN ESCLEROSIS LATERAL AMIOTROFICA (ELA)

RTI2018-098432-B-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE SEVILLA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Differential Interactome and Innate Immune Response Activation of Two Structurally Distinct Misfolded Protein Oligomers

  • Mannini, Benedetta
  • Vecchi, Giulia
  • Labrador-Garrido, Adahir
  • Fabre, Bertrand
  • Fani, Giulia
  • Franco, Jaime M.
  • Lilley, Kathryn
  • Pozo, David
  • Vendruscolo, Michele
  • Chiti, Fabrizio
  • Dobson, Christopher M.
  • Roodveldt, Cintia
The formation of misfolded protein oligomers during early stages of amyloid aggregation and the activation of neuroinflammatory responses are two key events associated with neurodegenerative diseases. Although it has been established that misfolded oligomers are involved in the neuroinflammatory process, the links between their structural features and their functional effects on the immune response remain unknown. To explore such links, we took advantage of two structurally distinct soluble oligomers (type A and B) of protein HypF-N and compared the elicited microglial inflammatory responses. By using confocal microscopy, protein pull-down, and high-throughput mass spectrometry, we found that, even though both types bound to a common pool of microglial proteins, type B oligomers - with a lower solvent-exposed hydrophobicity - showed enhanced protein binding, correlating with the observed inflammatory response. Furthermore, the interactome associated with inflammatory-mediated neurodegeneration revealed previously unidentified receptors and signaling molecules likely to be involved in the oligomer-elicited innate immune response., Financial support was provided by FEBS (Short-Term Fellowship to B.M.), EMBO (ASTF 450-2013 to B.M.), the Italian Society of Biochemistry and Molecular Biology (B.M.), the Spanish Ministry of Economy (RTC-2015-3309-1 to C.R., ISCIII CPII16/58 to C.R., PI14-1600 to D.P., and RTI2018- 098432-B-I00 to C.R. and D.P.), the Regional Ministry of Economy (P11-CTS-8161 and PAIDI2020 CTS-677 to D.P.), Programa “Atraccion de Talento ́ ”, University of Seville, and Programa “Ramon y Cajal ́ ”, Spanish Ministry of Economy (RYC-2017-23127 to C.R.). This work was also supported by the Cambridge Centre for Misfolding Diseases (B.M., G.V., G.F., M.V., C.M.D.).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Distinct responses of human peripheral blood cells to different misfolded protein oligomers

  • Leal-Lasarte, María M.
  • Mannini, Benedetta
  • Chiti, Fabrizio
  • Vendruscolo, Michele
  • Dobson, Christopher M.
  • Roodveldt, Cintia
  • Pozo, David
Increasing evidence indicates that peripheral immune cells play a prominent role in neurodegeneration connected to protein misfolding, which are associated with formation of aberrant aggregates, including soluble protein misfolded oligomers. The precise links, however, between the physicochemical features of diverse oligomers and their effects on the immune system, particularly on adaptive immunity, remain currently unexplored, due partly to the transient and heterogeneous nature of the oligomers themselves. To overcome these limitations, we took advantage of two stable and well-characterized types of model oligomers (A and B), formed by HypF-N bacterial protein, type B oligomers displaying lower solvent-exposed hydrophobicity. Exposure to oligomers of human peripheral blood mononuclear cells (PBMCs) revealed differential effects, with type B, but not type A, oligomers leading to a reduction in CD4 cells. Type A oligomers promoted enhanced differentiation towards CD4CD25FoxP3 Tregs and displayed a higher suppressive effect on lymphocyte proliferation than Tregs treated with oligomers B or untreated cells. Moreover, our results reveal Th1 and Th17 lymphocyte differentiation mediated by type A oligomers and a differential balance of TGF-β, IL-6, IL-23, IFN-γ and IL-10 mediators. These results indicate that type B oligomers recapitulate some of the biological responses associated with Parkinson's disease in peripheral immunocompetent cells, while type A oligomers resemble responses associated with Alzheimer's disease. We anticipate that further studies characterizing the differential effects of protein misfolded oligomers on the peripheral immune system may lead to the development of blood-based diagnostics, which could report on the type and properties of oligomers present in patients., Financial support was provided by the Spanish Ministry of Economy (RTI2018-098432-B-I00 to D.P. and C.R.), the Regional Ministry of Economy (PAIDI2020 CTS-677 to D.P.), Fundación ‘Ramón Areces’ (conv. 2018 to C.R.), Andalusian Regional Government-FEDER (US-1265227 to C.R.), Programa ‘Ramón y Cajal’ of the Spanish Ministry of Economy (RYC-2017-23127 to C.R.), FEBS (Short-Term Fellowship to B.M.), EMBO (ASTF 450-2013 to B.M.) and the Italian Society of Biochemistry and Molecular Biology (B.M.). This work was also supported by the Cambridge Centre for Misfolding Diseases, UK (B.M., M.V., C.M.D.).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Immune signaling kinases in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD)

  • García-García, Raquel
  • Martín-Herrero, Laura
  • Blanca-Pariente, Laura
  • Pérez-Cabello, Jesús Ángel
  • Roodveldt, Cintia
Amyotrophic lateral sclerosis (ALS) is the most common neurodegenerative disorder of motor neurons in adults, with a median survival of 3–5 years after appearance of symptoms, and with no curative treatment currently available. Frontotemporal dementia (FTD) is also an adult-onset neurodegenerative disease, displaying not only clinical overlap with ALS, but also significant similarities at genetic and pathologic levels. Apart from the progressive loss of neurons and the accumulation of protein inclusions in certain cells and tissues, both disorders are characterized by chronic inflammation mediated by activated microglia and astrocytes, with an early and critical impact of neurodegeneration along the disease course. Despite the progress made in the last two decades in our knowledge around these disorders, the underlying molecular mechanisms of such non-cell autonomous neuronal loss still need to be clarified. In particular, immune signaling kinases are currently thought to have a key role in determining the neuroprotective or neurodegenerative nature of the central and peripheral immune states in health and disease. This review provides a comprehensive and updated view of the proposed mechanisms, therapeutic potential, and ongoing clinical trials of immune-related kinases that have been linked to ALS and/or FTD, by covering the more established TBK1, RIPK1/3, RACK I, and EPHA4 kinases, as well as other emerging players in ALS and FTD immune signaling., Financial support to C.R. has been granted by the Spanish Ministry of Economy (RTI2018- 098432-B-I00), Fundación ‘Ramón Areces’ (CIVP19A5938), Andalusian Regional Government-FEDER (US-1265227) and I+D PAIDI (PY20_01097), and ‘Programa Ramón y Cajal’ of the Spanish Ministry of Economy (RYC-2017-23127).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Editorial: Nanoparticle-Mediated Signaling Rewiring and Reprogramming of Immune Responses

  • Quintana, Francisco J.
  • Pozo, David
Recent advances on the molecular mechanisms that control immune cells are at the core of the development of better immunomodulatory therapies. For example, these mechanisms may enable T cell manipulation interventions to treat and prevent autoimmune disease by rewiring T cells towards an anti-inflammatory phenotype. Indeed, it has been recently reported that metabolic sensing in immune cells is coupled to signal transduction pathways that control cell fate. These phenomena have been linked to the onset and/or progression of several diseases such as multiple sclerosis, rheumatoid arthritis, diabetes or Alzheimer’s disease, and also exploited therapeutically to develop cancer immunotherapies (1–4). Unifying our understanding of the molecular pathways that control the immune response might identify novel efficacious interventions to reprogram immune cells for therapeutic purposes in diseases associated with immune dysregulation. However, two important challenges limit the clinical translation of our current knowledge on the regulation of the immune response by small molecules which could provide the basis for novel immunotherapeutic drugs. First, the absence of mechanisms to control the specificity of these reprogramming approaches, resulting in off-target effects. Second, limitations associated to the short half-life and/or low bioavailability of immune-modulatory small molecules., DP is supported by the Regional Ministry of Transformación Económica, Industria, Conocimiento y Universidades, PAID2020, CTS677 to DP) and the Spanish Government Ministry of Science and Innovation of Spain [RTI2018-098432-B-I00, co-funded by the European Regional Development Fund (ERDF), a way to build Europe]. FQ is supported by the National Institutes of Health, the Progressive Multiple Sclerosis Alliance and the National Multiple Sclerosis Society.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

MAPK/MAK/MRK overlapping kinase (MOK) controls microglial inflammatory/type-I IFN responses via Brd4 and is involved in ALS

  • Pérez-Cabello, Jesús Ángel
  • Silvera-Carrasco, Lucía
  • Franco, Jaime M.
  • Capilla-González, Vivian
  • Armaos, Alexandros
  • Gómez-Lima, María
  • García-García, Raquel
  • Yap, Xin Wen
  • Leal-Lasarte, Magdalena
  • Lall, Deepti
  • Baloh, Robert H.
  • Martínez, Salvador
  • Miyata, Yoshihiko
  • Tartaglia, Gian G.
  • Sawarkar, Ritwick
  • García-Domínguez, Mario
  • Pozo, David
  • Roodveldt, Cintia
Amyotrophic lateral sclerosis (ALS) is a fatal and incurable neurodegenerative disease affecting motor neurons and characterized by microglia-mediated neurotoxic inflammation whose underlying mechanisms remain incompletely understood. In this work, we reveal that MAPK/MAK/MRK overlapping kinase (MOK), with an unknown physiological substrate, displays an immune function by controlling inflammatory and type-I interferon (IFN) responses in microglia which are detrimental to primary motor neurons. Moreover, we uncover the epigenetic reader bromodomain-containing protein 4 (Brd4) as an effector protein regulated by MOK, by promoting Ser-phospho-Brd4 levels. We further demonstrate that MOK regulates Brd4 functions by supporting its binding to cytokine gene promoters, therefore enabling innate immune responses. Remarkably, we show that MOK levels are increased in the ALS spinal cord, particularly in microglial cells, and that administration of a chemical MOK inhibitor to ALS model mice can modulate Ser-phospho-Brd4 levels, suppress microglial activation, and modify the disease course, indicating a pathophysiological role of MOK kinase in ALS and neuroinflammation., We are extremely grateful to Prof. Kevan Shokat and Dr. Flora Rutaganira, University of California, San Francisco (San Francisco, USA) for kindly supplying us with C13 compound. We thank patients’ associations (Saca la lengua a la ELA, Juntos contra la ELA, and Reto Todos Unidos/Miquel Valls Fundació Catalana D’ELA) for supporting the PAIDI Research Group (CTS-0160) global mission. Financial support to C.R. was provided by the Spanish Ministry of Economy (RTI2018-098432-B-I00), Fundación Ramón Areces (CIVP19A5938), the Andalusian Regional Government-FEDER (US-1265227), and I+D PAIDI (PY20-01097). Funding to D.P. was given by the PAIDI research group (CTS-0160) and Regional Ministry of Health (PI-0232-2022). V.C-G. is supported by the Institute of Health Carlos III, Spain, cofunded by the European Social Fund (CP19/00046). S.M. was supported by Generalitat Valenciana (GVA: Prometeo/2018/041 and CIPROM/2021/018); the Spanish Ministry of Economy, Industry and Competitiveness (MINECO), the Spanish State Research Agency (AEI) cofunded by European Regional Development Fund (ERDF), European Union (PID2020-118171RB-100); and Instituto de Salud Carlos III (RD16/001/0010, cofunded by ERDF).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

VEGF expression disparities in brainstem motor neurons of the SOD1G93A ALS model: Correlations with neuronal vulnerability

  • Silva-Hucha, Silvia
  • Fernández de Sevilla, M. Estrella
  • Humphreys, Kirsty M.
  • Benson, Fiona E.
  • Franco, Jaime M.
  • Pozo, David
  • Pastor, Ángel M.
  • Morcuende, Sara
Amyotrophic lateral sclerosis (ALS) is a rare neuromuscular disease characterized by severe muscle weakness mainly due to degeneration and death of motor neurons. A peculiarity of the neurodegenerative processes is the variable susceptibility among distinct neuronal populations, exemplified by the contrasting resilience of motor neurons innervating the ocular motor system and the more vulnerable facial and hypoglossal motor neurons. The crucial role of vascular endothelial growth factor (VEGF) as a neuroprotective factor in the nervous system is well-established since a deficit of VEGF has been related to motoneuronal degeneration. In this study, we investigated the survival of ocular, facial, and hypoglossal motor neurons utilizing the murine SOD1G93A ALS model at various stages of the disease. Our primary objective was to determine whether the survival of the different brainstem motor neurons was linked to disparate VEGF expression levels in resilient and susceptible motor neurons throughout neurodegeneration. Our findings revealed a selective loss of motor neurons exclusively within the vulnerable nuclei. Furthermore, a significantly higher level of VEGF was detected in the more resistant motor neurons, the extraocular ones. We also examined whether TDP-43 dynamics in the brainstem motor neuron of SOD mice was altered. Our data suggests that the increased VEGF levels observed in extraocular motor neurons may potentially underlie their resistance during the neurodegenerative processes in ALS in a TDP-43-independent manner. Our work might help to better understand the underlying mechanisms of selective vulnerability of motor neurons in ALS., This work has been funded by the I+D+i project PID2021-124300NB-I00 of MICIU/AEI/10.13039/501100011033/ and by FEDER. A way of making Europe (A.M.P.). Research materials were also funded by Project P20-00529 Consejería de Transformación Económica, Industria y Conocimiento, Junta de Andalucía-FEDER (A.M.P.), and by BIO-297 (A.M.P.) and CTS-677 (D.P.). This paper was also part of the I+D+i project PGC2018-094654-B-100 supported by MCIN/AEI/10.13039/501100011033, FEDER “A way of making Europe” (A.M.P.). Also supported by FEDER/Ministerio de Economía y Competitividad - Agencia Estatal de Investigación in Spain. Project RTI2018-098432-B-I00 (D.P.). This work was partly financed by Consejería de Salud y Consumo de la Junta de Andalucía (PI-0232-2022) (D.P.), competitive grant call “Investigación, Desarrollo e Invovación (I+D+i) en Biomedicina y en Ciencias de la Salud en Andalucía, 2002. Institutional Review Board Statement: Reviewed and approved by the ethics committee of Universidad de Sevilla (CEEA-US2015-15/3) and CABIMER (CEEA-CABIMER; CEEA 25–2010). Stereological procedures and confocal microscopy were performed at the Central Research Services of Universidad de Sevilla (CITIUS). This work is dedicated to the memory of Prof David Allsop (Lancaster University, UK)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

PSMA-targeted delivery of docetaxel in prostate cancer using small-sized PDA-based micellar nanovectors

  • Rosales-Barrios, Cristian
  • González-Sánchez, Zaida
  • Zuliani, Alessio
  • Jiménez-Vacas, Juan M.
  • Luque, Raul M
  • Pozo, David
  • Khiar, Noureddine
In this study, we present the first comparative analysis of active and passive drug delivery systems for docetaxel (DTX) in prostate cancer using supramolecular self-assembled micellar nanovectors. Specifically, we developed two novel micelles based on polydiacetylenic amphiphiles (PDA) for passive and active targeting. The active targeting micelles were designed with a prostate-specific membrane antigen (PSMA) ligand, ACUPA, to facilitate recognition by PSMA-positive cancer cells. These PDA-based micelles feature a well-defined structure with a hydrophobic PDA core and a surface functionalized with PEG, and for active targeting, ACUPA. Our micelles demonstrated excellent encapsulation capacity, significantly improving DTX solubility in water, a crucial factor for clinical drug use. In vitro studies confirmed the safety and cytotoxic profiles of both systems, with ACUPA-functionalized micelles showing notable internalization into PSMA-positive LNCaP cells, mediated through the PSMA-ACUPA interaction. In vivo imaging revealed preferential accumulation of ACUPA-functionalized nanomicelles in LNCaP xenograft tumors, suggesting enhanced retention via specific ACUPA-PSMA interactions and active uptake by LNCaP cells. Notably, Balb/c-Foxn1nu/nu early in vivo studies showed a marked reduction in tumor volume and tumor expression levels of proliferation, cell cycle progression, cell survival and anti-apoptotic markers with DTX-loaded micelles functionalized with ACUPA compared to those without ACUPA. Overall, our studies collect initial evidence regarding the feasibility of supramolecular self-assembly of ACUPA-PDA-based nanomicelles for PSMA-targeted drug chemotherapy delivery developments., Financial support was provided by the Spanish Ministry of Science and Innovation (Ref: PID2020-119949RB-I00 and PID2023-152689OB-I00 to NK; RTI2018-098432-B-100 to DP, PID2022-1381850B-I00 to RML), the Andalusian Ministry of Economy, Science and Innovation cofinanced by the European Regional Development Fund (ERDF) from FEDER and the European Social Fund (ESF) (PY20_00882 and CV20-04221 to NK, and postodoctoral fellowship “POSTDOC_21_00594” to AZ), the CSIC (CSIC-COV19-047 to NK), Andalusian Ministry of Health (PI-0232-2022 to ZGS and DP) and the PAIDI Program from the Andalusian Government (FQM-313 to NK). The COST action CA-18132 “Functional Glyconanomaterials for the Development of Diagnostic and Targeted Therapeutic Probe” is also acknowledged. ZGS holds a postdoctoral fellowship from the María Zambrano program (21-20073; Spanish Government, Ministry of Universities, NextGeneration EU). We also thank the Centre of Research Technology and Innovation of the University of Seville (CITIUS) for the use of TEM, HRMS and NMR facilities., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Stainless Steel-Synthesized gold Nanoparticles: Insights into Blood-Brain barrier permeability and microglial interaction

  • González-Sánchez, Zaira I.
  • López-Lorente, Ángela Inmaculada
  • Castillo-González, Julia
  • González-Rey, Elena
  • Cárdenas, Soledad
  • Pozo, David
Effective drug delivery to the Central Nervous System (CNS) remains a formidable challenge in neurotherapeutics, primarily due to the restrictive Blood-Brain Barrier (BBB). Gold nanoparticles (AuNPs) are emerging as promising tools to bypass this barrier and manage neuroinflammation, key factor in numerous neurological disorders. In this work, we evaluate the potential of highly stable, small-sized AuNPs-synthesized via an environmentally benign method using stainless steel-as a dual-function nanocarrier system for CNS applications. We specifically investigate their capacity for BBB permeability using in vitro models and their subsequent interaction with resident immune cells (microglia), which is critical for safety and efficacy. We demonstrate that stainless steel-synthesized AuNPs (ss-AuNPs) effectively cross the barrier without compromising its integrity. In microglial cells, ss-AuNPs exhibited dose-dependent cytotoxic effects, with higher concentrations reducing cell viability while inducing minimal inflammatory responses. Similarly, in primary microglial cultures, ss-AuNPs at higher doses stimulated interleukin-6 (IL-6) release, although no significant pro-inflammatory activation was observed at lower doses. These results highlight the potential of green-synthesized AuNPs for CNS-targeted applications, validating their promise as stable and safe nanocarriers for future drug formulation targeting neurological diseases., Z.I. González-Sánchez wishes to thank Ministry of Science and Technology, Dominican Republic, for funding Projects FONDOCyT 2014-1B3-051 and 2015-3A6-138 to Z.I.G-S. Z.I. This work was also supported by the Spanish Ministry of Science and Innovation (MCIN)/AEI/ 10.13039/501100011033 and by “ERDF A way of making Europe” grants PID2020–119638RB-I00 (to E.G-R.) and by RTI2018-098432-B-100 (to D.P), and by FPU-program FPU17/02616 (to J.C-G.O) and María Zambrano program (21-20073; Spanish Government, Ministry of Universities, NextGeneration EU to Z.I.G-S) and the Andalusian Ministry of Health (PI-0232-2022 to ZG and DP) and the PAIDI Program from the Andalusian Government (CTS-677 to DP)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Gold-iron oxide multicomponent nanoparticles differentially modulate TLR signaling in Microglia: a comparative study using primary and immortalized models

  • González-Sánchez, Zaira I.
  • Caro, Carlos
  • Quaresma, Pedro
  • Pereira, Eulália
  • Pozo, David
Hybrid iron oxide–gold nanoparticles have attracted considerable interest for nanomedical applications, particularly in drug delivery and imaging. However, their immunomodulatory profile, especially on microglia—the primary immune cells of the central nervous system (CNS)—remains largely unexplored. Here, we investigate the effects of synthesized multicomponent nanoparticles (MCNPs), composed of Fe<inf>3</inf>O<inf>4</inf>–AuNPs with spheroidal and soft-spiky morphologies, on the immune-mediated functional response of microglia. Differential immune activation was assessed using both an immortalized microglial cell line (SIM-A9) and primary microglial cultures. Notably, Fe<inf>3</inf>O<inf>4</inf>-AuNPs selectively modulate cytokine release (TNF-α and IL-6) upon specific stimulation of Toll-like receptors (TLRs), revealing a nuanced interaction with immune signaling pathways. Importantly, cytokine secretion profiles differed markedly between primary microglia and established cell lines, underscoring the necessity of physiologically relevant models to avoid misleading conclusions and to improve the translational potential of nanoparticle-based therapeutic strategies for neurodegenerative diseases., Z.I. González-Sánchez holded a María Zambrano fellowship funded by the “European Union – NextGenerationEU”. This work was also supported by the Spanish Ministry of Science and Innovation (MCIN/AEI) grant RTI2018-098432-B-100 (to D.P), the Andalusian Ministry of Health (PI-0232-2022 to ZG and DP) and the PAIDI Program from the Andalusian Government (CTS-677 to DP)., Peer reviewed